GSK Stock 12 Month Analyst Forecast
Eps Overview
Growth Next 5yrs
5.9%
Last Quarter
$1.46
Past Year
$3.66
Growth Past 5yrs
0.08%
Next Quarter
$1.19
Estimate Next Year
$0.56
Consensus Rating
Loading...
Consensus Price Target
Highest Price Target
N/A
0% Upside
Mean Price Target
N/A
0% Upside
Lowest Price Target
N/A
0% Upside
Recent Analyst Ratings
Upgrades, Downgrades, New Coverage
Actual EPS vs Estimated EPS
GSK Earnings Per Share (EPS) History
According to financial reports, GSK (NYSE: GSK) reported an actual EPS of $1.46 for the quarter ending on Oct 29, 2025, compared to an estimated $1.26, resulting in a 15.87% surprise. In the prior quarter (Jul 30, 2025), GSK recorded an actual EPS of $1.23 with a 9.82% surprise. See GSK's full earnings history.
Earnings History
EPS Surprise Factor Analysis
GSK has experienced notable EPS surprises, with the latest quarter ending Oct 29, 2025 showing a 15.87% beat. Previously, the quarter ending Jul 30, 2025 recorded a 9.82% beat. An EPS surprise factor indicates how much actual earnings deviate from analyst forecasts.
| Report Date | Actual | Forecast | Surprise Factor |
|---|---|---|---|
| Oct 29, 2025 | 1.46 | 1.26 | +15.87% |
| Jul 30, 2025 | 1.23 | 1.12 | +9.82% |
| Apr 30, 2025 | 1.13 | 1.08 | +4.63% |
| Feb 05, 2025 | 0.59 | 0.44 | +34.09% |
| Oct 30, 2024 | 1.27 | 1.16 | +9.48% |
| Jul 31, 2024 | 1.09 | 1 | +9.00% |
Frequently Asked Questions
Is GSK stock getting favorable reviews from Wall Street analysts?
Brokerage firms have given GSK stock an average recommendation of
N/A. 0 analysts have given their ratings
to GSK out of which
0 analysts have given strong buy call,
0 analysts have given buy call,
0 analysts rate it hold,
0 analysts advocate strong sell call, and
0 analysts has given sell rating. The average target price of
- gives the stock implied downside
of roughly 0% over the next year or so.
What have analysts suggested for GSK highest price target?
Analysts suggest GSK's stock price would rise to a high of -.
What is the lowest price target analysts expect for GSK over the next year?
Within the next 12 months, analysts predict the GSK stock price could move to -.
What is the average target price for GSK?
GSK stock has an average analyst estimate of -.
At its current price, how far is GSK from its average target price?
GSK shares are currently trading 0% below this price target.
What were GSK’s actual earnings per share for the recent quarter?
Its quarterly earnings per share (EPS) came in at $1.46 versus consensus estimates of $1.26, and above the comparable year-ago quarter’s EPS of $1.27.
What are the current estimates for quarterly and annual earnings per share?
GSK's forecasts by analysts estimating quarterly EPS at $1.19 and $0.56 for the whole year.
What has GSK's growth been in the past five years and what is expected in the next five years?
The analysts have projected 5.9% EPS growth for GSK in the next five years, compared to growth rates of 0.08% in the past five years.